In a 35-year-old woman with hepatic steatosis and a non‑shadowing echogenic focus in the gallbladder, is the lesion a polyp or a small stone?

Distinguishing Gallbladder Polyp from Small Stone

The non-shadowing echogenic focus in this 35-year-old woman is most likely a small gallstone or tumefactive sludge rather than a true polyp, and the key distinguishing feature is mobility on positional change during ultrasound.

Critical Diagnostic Approach

The 2022 Society of Radiologists in Ultrasound (SRU) consensus guidelines provide clear definitions that directly address this scenario 1:

Key Distinguishing Features

Gallstones are defined as:

• Solid shadowing hyperechoic structures (though small stones may not shadow)
• Mobile with patient repositioning
• Generally hyperechoic

True polyps are defined as:

• Non-mobile, non-shadowing protrusions
• Fixed to the gallbladder wall
• Not attributable to gallstones or sludge

The Critical Test: Mobility Assessment

Perform a repeat ultrasound with the patient in different positions (supine, left lateral decubitus, upright if possible). If the echogenic focus moves with gravity, it is a stone or sludge—not a polyp 1.

Size-Based Interpretation

The clinical significance varies dramatically by size:

• Lesions <5 mm: 83% have no lesion found on final pathology 2. In one classic study, 81% of non-shadowing echogenic foci <5 mm were gallstones at surgery 3

• The smaller the lesion, the more likely it represents a pseudo-mass rather than a true pathologic entity 2

When Uncertainty Persists

If you cannot distinguish between tumefactive sludge/stone versus polyp after optimized technique 1:

1. Short-interval follow-up ultrasound in 1-2 months with:

   • Optimized grayscale technique
   • Color/power Doppler
   • Patient fasting for gallbladder distention

2. Consider contrast-enhanced ultrasound (CEUS) if available:

   • Tumefactive sludge will show no internal enhancement (avascular) 1
   • True polyps typically show internal vascularity
   • CEUS has 90% accuracy for differentiating cholesterol polyps 1

3. MRI as alternative if CEUS unavailable:

   • High T1 signal suggests cholesterol polyp or pigment stone 1
   • Tumefactive sludge shows no post-gadolinium enhancement 1

Clinical Context: Hepatic Steatosis

The presence of hepatic steatosis is relevant but does not change the diagnostic approach. While MASLD (metabolic dysfunction-associated steatotic liver disease) affects 30% of the population 4, there is no established direct relationship between hepatic steatosis and gallbladder polyp formation. However, both conditions share metabolic risk factors.

Common Pitfalls to Avoid

• Don't assume all non-shadowing foci are polyps: Small stones frequently don't shadow due to their size relative to the ultrasound beam width
• Don't skip positional maneuvers: This is the single most important distinguishing feature
• Don't over-interpret tiny lesions: Most apparent lesions <5 mm are not identified in surgical specimens 2
• Don't use CT for this differentiation: CT is inferior to ultrasound, CEUS, or MRI for characterizing gallbladder lesions 1

Management Based on Findings

If confirmed mobile (stone/sludge):

• Manage based on symptoms
• No surveillance needed for asymptomatic findings

If confirmed fixed polyp:

• Size <10 mm in a 35-year-old: No immediate action needed; consider surveillance only if ≥6 mm 1
• The negative predictive value for malignancy is 100% for polyps ≤9 mm 2
• Risk of invasive cancer in polyps <10 mm is extraordinarily low 5